  Certainly! I'd be happy to help you review the interaction you had with the patient. Here are my answers to your 4 questions:
1. Is the treatment consistent with the diagnosis?
Yes, the treatment plan you outlined is consistent with the diagnosis of peptic ulcer with perforation. Clarithromycin and metronidazole are both effective antibiotics for treating Helicobacter pylori infections, which are a common cause of peptic ulcers. Omeprazole is also a appropriate medication for managing peptic ulcer symptoms, such as acid secretion reduction.
2. Is the diagnosis consistent with the observations?
Yes, the patient's history of peptic ulcer with chest pain for 3 days is consistent with the diagnosis of peptic ulcer with perforation. Chest pain can be a common symptom of peptic ulcer perforation, especially if the ulcer is located in the stomach rather than the duodenum.
3. Are there other things you would test, but only tests that might be available in rural health clinics?
In a rural health clinic setting, it may be challenging to perform more extensive diagnostic tests such as endoscopy or imaging studies. However, you could consider testing for Helicobacter pylori infection using an immunofluorescent assay, as you mentioned in the patient's chart. This test can help confirm the presence of H. pylori infection, which is a common cause of peptic ulcers.
4. Is there anything else notable?
Yes, it's worth noting that the patient's blood pressure of 125/80 mmHg is elevated, which may be a sign of hypertension. Hypertension is a common comorbidity with peptic ulcer disease and can increase the risk of complications. It would be important to monitor the patient's blood pressure and consider initiating antihypertensive therapy if necessary.
Overall, it seems like you have a solid diagnosis and treatment plan for the patient. However, it's important to continue monitoring the patient's condition and adjusting the treatment plan as needed based on their response to therapy and any additional symptoms that may arise.